GENELUX Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8,000 | $8,000 | $170,000 | $11.1M | — |
| Research and development | $19.9M | $19.0M | $12.8M | $9.1M | — |
| Operating expenses | $33.2M | $31.7M | $24.3M | $14.1M | — |
| Operating income | -$33.2M | -$31.7M | -$24.2M | -$3.0M | — |
| Interest expense | — | — | $173,000 | — | — |
| Income tax expense | — | — | — | $1.1M | — |
| Net income | -$32.1M | -$29.9M | -$28.3M | -$5.2M | — |
| Balance Sheet | |||||
| Cash and equivalents | $5.3M | $8.6M | $9.4M | $397,000 | — |
| Current assets | $15.1M | $31.5M | $24.2M | $1.9M | — |
| Total assets | $19.0M | $34.7M | $27.9M | $5.5M | — |
| Current liabilities | $6.2M | $6.9M | $6.6M | $31.6M | — |
| Total liabilities | $7.5M | $8.4M | $8.4M | $41.3M | — |
| Total debt | — | — | — | $9.1M | — |
| Stockholders' equity | $11.5M | $26.3M | $19.5M | -$35.8M | -$33.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$25.3M | -$21.2M | -$20.3M | -$3.6M | — |
| Depreciation and amortization | $244,000 | $235,000 | $499,000 | $553,000 | — |
| Stock-based compensation | $5.9M | $5.7M | $2.5M | $2.4M | — |
| Capital expenditure | $1.1M | $381,000 | $1.0M | $49,000 | — |
| Free cash flow | -$26.4M | -$21.6M | -$21.3M | -$3.6M | — |
Shares outstanding 44.8M · Free float 85.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.